Cutting edge microwave imaging device for safe and accurate breast cancer screen...
Cutting edge microwave imaging device for safe and accurate breast cancer screening
Breast cancer (BC) is the most prevalent form of cancer in women. One in nine women will acquire BC at some point in their life and one in thirty will die from the disease . Most EU countries have adopted mass BC screening program...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Información proyecto MammoWave
Duración del proyecto: 34 meses
Fecha Inicio: 2018-10-10
Fecha Fin: 2021-08-31
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Breast cancer (BC) is the most prevalent form of cancer in women. One in nine women will acquire BC at some point in their life and one in thirty will die from the disease . Most EU countries have adopted mass BC screening programmes as a way for detecting the disease early, using tools such as mammography machines. Mammography has been the medical industry’s gold standard breast cancer screening tool for nearly four decades. However, a number of adverse effects, backed up by mounting scientific evidence, are now limiting the use of mammography as a mass screening device.
MammoWave is a revolutionary BC screening device for highly accurate cancer detection based on safe microwaves instead of ionizing radiation (X-rays).
The excellent overall sensitivity (ongoing clinical trials show sensitivity above 90%), the simple method that requires no squishing of the breast, and the complete safety of the microwave imaging technique, make MammoWave primed for mass BC screening.